肝病患者尿中二甲色胺的排泄情况。
Urinary excretion of dimethyltryptamine in liver disease.
作者信息
Checkley S A, Oon M C, Rodnight R, Murphy M P, Williams R S, Birley J L
出版信息
Am J Psychiatry. 1979 Apr;136(4A):439-41.
PMID:284722
Abstract
The urinary excretion of N,N-dimethyltryptamine (DMT) was higher in patients with severe liver disease than in normal subjects. This difference remained significant when patients with all grades of hepatic encephalopathy were excluded. Patients with liver disease whose mental states were normal excreted amounts of DMT similar to those of patients with a hospital diagnosis of schizophrenia.
摘要
严重肝病患者尿中N，N - 二甲基色胺（DMT）的排泄量高于正常受试者。排除所有等级肝性脑病患者后，这种差异仍然显著。精神状态正常的肝病患者排泄的DMT量与医院诊断为精神分裂症的患者相似。
相似文献
1
Urinary excretion of dimethyltryptamine in liver disease.肝病患者尿中二甲色胺的排泄情况。
Am J Psychiatry. 1979 Apr;136(4A):439-41.
2
The excretion of dimethyltryptamine in psychiatric patients.精神科患者中二甲色胺的排泄情况。
Proc R Soc Med. 1976 Nov;69(11):831-2. doi: 10.1177/003591577606901122.
3
A longitudinal study of urinary excretion of N,N,-dimethyltryptamine in psychotic patients.精神病患者尿液中N，N-二甲基色胺排泄情况的纵向研究。
Br J Psychiatry. 1980 Sep;137:236-9. doi: 10.1192/bjp.137.3.236.
4
Increased excretion of dimethyltryptamine and certain features of psychosis: a possible association.二甲基色胺排泄增加与精神病的某些特征：一种可能的关联。
Arch Gen Psychiatry. 1979 Jun;36(6):644-9. doi: 10.1001/archpsyc.1979.01780060034003.
5
Urinary dimethyltryptamine and psychiatric symptomatology and classification.尿中二甲色胺与精神症状学及分类
Psychol Med. 1976 Nov;6(4):649-57. doi: 10.1017/s0033291700018304.
6
7
8
Factors affecting the urinary excretion of endogenously formed dimethyltryptamine in normal human subjects.影响正常人体受试者内源性生成的二甲基色胺尿排泄的因素。
Psychopharmacology (Berl). 1977 Oct 20;54(2):171-5. doi: 10.1007/BF00426775.
9
Urinary excretion of n,n-dimethylated tryptamines in chronic schizophrenia. A review of the present status of the hypothesis.
Can Psychiatr Assoc J. 1976 Dec;21(8):541-6. doi: 10.1177/070674377602100808.
10
Evidence for and against the involvement of N,N-dimethyl-tryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in schizophrenia.
Psychopharmacol Bull. 1976 Oct;12(4):12-3.
引用本文的文献
1
The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders.腺苷蛋氨酸（S-腺苷甲硫氨酸）在神经疾病中的临床潜力。
Drugs. 1994 Aug;48(2):137-52. doi: 10.2165/00003495-199448020-00002.
2
CNS tryptamine metabolism in hepatic coma.肝昏迷时中枢神经系统色胺代谢
J Neural Transm. 1980;47(3):153-61. doi: 10.1007/BF01250597.
Zotero 插件